C4 Therapeutics Inc 2024 Sustainability Report
Company: C4 Therapeutics Inc
Sector: Manufacturing
Country: United States
Year: 2024
Type: Sustainability Report
Pages: 5
The report describes the company’s ESG priorities, including board-level oversight through its Nominating and Corporate Governance Committee. Its 2024 human-capital results include strong employee perceptions of mission, equal opportunity, flexibility, and social responsibility, alongside pay-equity reviews and inclusive workplace training. The company also reports implemented cybersecurity controls, including annual staff training, phishing tests, identity protection, multifactor authentication, and 24/7 monitoring.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.